Evonik is a German specialty chemicals group that develops additives, intermediates, and high-performance materials rather than bulk commodity chemicals alone. Its portfolio supports industries such as automotive, construction, consumer goods, nutrition, and healthcare with tailored formulations and process solutions. Differentiation rests on application know-how, custom products, and long-term customer relationships in specialty chemical niches.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 3,599 | — | -152 | — |
| Q1 2025 | 3,777 | — | 233 | 17% |
| Q2 2025 | 3,499 | — | 120 | -48.5% |
| Q4 2025 | 3,403 | -5.5% | 18 | — |
| Q1 2026 | 3,427 | -9.3% | 125 | -46.4% |
| Q2 2026 | 3,893 | 11.3% | 84 | -30% |
All markets — KeepWinning global stock screener
Other companies on MDAX: Nordex (NDX1), Hella (HLE), Nemetschek (NEM), Aurubis (NDA), Rational (RAA), Fraport (FRA)